Bon Natural Life Limited Announces Brand Strategic Cooperation with Guangdong JUWO
XI’AN, China, May 14, 2024 (GLOBE NEWSWIRE) — Bon Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), one of […]
Century Aluminum Company Applauds Biden Administration Decision To Triple Chinese Aluminum Tariffs
CHICAGO, May 14, 2024 (GLOBE NEWSWIRE) — President Biden today announced that his administration would triple existing tariffs on Chinese […]
Organovo to Present Data on FXR314 at Digestive Diseases Week (DDW2024)
SAN DIEGO, May 14, 2024 (GLOBE NEWSWIRE) — Organovo Holdings, Inc. (Nasdaq:ONVO), a clinical stage biotechnology company focused on developing […]
Progyny, Inc. to Present at BofA Securities 2024 Healthcare Conference and Leerink Partners Healthcare Crossroads Conference 2024
NEW YORK, May 14, 2024 (GLOBE NEWSWIRE) — Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health […]
Atlantic American Corporation Reports First Quarter Results for 2024
ATLANTA, May 14, 2024 (GLOBE NEWSWIRE) — Atlantic American Corporation (Nasdaq- AAME) today reported net loss of $2.0 million, or […]
Disc Medicine Announces Multiple Presentations Across Portfolio at the European Hematology Association (EHA) 2024 Congress
Additional analyses of data from AURORA, as well as the full adult data set from BEACON Updated data from the […]
Affimed Announces Acceptance of an Abstract on Preclinical Data of its Innate Cell Engager AFM28 at the European Hematology Association 2024 Congress
Treatment with AFM28 innate cell engager (ICE®), designed to target CD123-positive cancer cells in patients with acute myeloid leukemia (AML), […]
Trust Stamp Provides a Business Report and Financial Results for the Three Months Ended March 31, 2024
ATLANTA, May 14, 2024 (GLOBE NEWSWIRE) — Trust Stamp (Nasdaq: IDAI), the Privacy-First Identity Company™ providing AI-powered trust and identity […]
IN8bio Announces Upcoming Presentation at 2024 European Hematology Association Congress
NEW YORK, May 14, 2024 (GLOBE NEWSWIRE) — IN8bio, Inc. (Nasdaq: INAB) a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell […]
Autolus Therapeutics to Present Three Clinical Data Updates on obecabtagene autoleucel (obe-cel) in relapsed/refractory (r/r) B-Cell acute lymphoblastic leukemia (ALL) patients at the 2024 European Hematology Association (EHA) Congress
LONDON, May 14, 2024 (GLOBE NEWSWIRE) — Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell […]
